GSWM
KPRX icon

Golden State Wealth Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Golden State Wealth Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5
Closed -$7K – 338
2020
Q3 		$7K Buy
+5
New +$7.87K ﹤0.01% 410
2020
Q2 		– Sell
-5
Closed -$9K – 586
2020
Q1 		$9K Buy
+5
New +$10.8K ﹤0.01% 642
2019
Q4 		– Sell
-5
Closed -$6K – 542
2019
Q3 		$6K Hold
5
– – ﹤0.01% 830
2019
Q2 		$6K Hold
5
– – ﹤0.01% 839
2019
Q1 		$8K Buy
+5
New +$12.2K ﹤0.01% 812

Other funds holding KPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SFP
Sterling Financial Planning Sparta, New Jersey $337M AUM 19.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Golden State Wealth Management's KPRX Position: Q4 2020 in Review

Golden State Wealth Management sold out of Kiora Pharmaceuticals (KPRX) in Q4 2020, closing a stake of 5 shares — an estimated $7K sold.

Golden State Wealth Management first reported a position in KPRX in Q1 2019 and held it in 5 quarters. The position peaked at $9K in Q1 2020. 12 funds tracked by Wall St. Rank hold KPRX as of Q4 2020.

  • Golden State Wealth Management reported no remaining Kiora Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Golden State Wealth Management sold 5 Kiora Pharmaceuticals shares in Q4 2020, an estimated $7K.
  • Golden State Wealth Management first reported a position in Kiora Pharmaceuticals in Q1 2019 and held it in 5 quarters.
  • Golden State Wealth Management's Kiora Pharmaceuticals position peaked at $9K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q4 2020.

Based on Golden State Wealth Management's 13F filing for Q4 2020, filed 28 Jan 2021.